In Vivo and in Vitro Models of Demyelinating Disease. Possible Relationship between Induction of Regulatory Subunit from cAMP Dependent Protein Kinases and Inhibition of JHMV Replication in Cultured Oligodendrocytes

  • G. A. R. Wilson
  • D. V. Mohandas
  • S. Dales
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 276)


Among the parameters controlling Coronavirus (CV) replication within the nervous system of rodents is the state of glial-cell maturation.1,14 Thus differentiation of primary cultures of oligodendrocytes with dibutyryl cAMP (dbcAMP) effectively results in a restriction of CV-JHMV replication. Treatment of cells with dbcAMP, which directly raises the intracellular concentration of cAMP, stimulates the adenylate cyclase system. In primary rat oligodendrocytes stimulation of the adenylate cyclase system results in an induction of the regulatory subunit (R) of cAMP-dependent protein kinase type 1 (PK1).2 It is conceivable that the function of increase in free R1 within host-cells may be related to inhibition of phosphoprotein phosphatases (PPPase), as previously demonstrated in rabbit skeletal muscle with R2 from PK2.6,7. Evidence from our studies indicates that a PPPase may participate in the early stages of CV infection, perhaps during traverse through endosomes of the host.12 The present study was undertaken to ascertain whether the R protein plays any role in restricting JHMV replication in mature glial cells by inhibiting an endosomal PPPase.


Regulatory Subunit Demyelinating Disease Rabbit Skeletal Muscle Mouse Hepatitis Virus Dibutyryl cAMP 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    S. Beushausen and S. Dales, In-vivo and in-vitro models of demyelinating disease XI. Tropism and differentiation regulate the infectious process of coronaviruses in primary explants of the rat CNS, Virol. 141:89–101 (1985).CrossRefGoogle Scholar
  2. 2.
    S. Beushausen, S. Narindrasorasak, B. D. Sanwal, and S. Dales, In-vivo and in-vitro models of demyelinating disease: Activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes, J. Virol. 61:3795–3803 (1987).PubMedGoogle Scholar
  3. 3.
    C. J. Budzilowicz, S. P. Wilczynski, and S. R. Weiss, Three intergenic regions of Coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucletide sequence that is homologous to the 3’ end of the viral mRNA leader sequence, J. Virol. 53:834–840 (1985).PubMedGoogle Scholar
  4. 4.
    M. Coulter-Mackie, R. Adler, G. A. R. Wilson, and S. Dales, In-vivo and in-vitro models of demyelinating diseases. XII. Persistence and expression of corona JHM virus functions in RN2–2 schwannoma cells during latency, Virus Res. 3:245–261 (1985).PubMedCrossRefGoogle Scholar
  5. 5.
    J. F. David-Ferreira and R. A. Manaker, An electron microscope study of the development of a mouse hepatitis virus in tissue culture cells, J. Cell Biol. 24:57–58 (1965).PubMedCrossRefGoogle Scholar
  6. 6.
    S. R. Jurgensen, P. B. Chock, S. Taylor, J. R. Vandenheede, and W. Merlevede, Inhibition of the Mg(II)-ATP-dependent phosphoprotein phosphatase by the regulatory subunit of cAMP dependent protein kinase. Proc. Natl. Acad. Sci. USA 82:7565-7569.Google Scholar
  7. 7.
    B. S. Khatra, R. Printz, C. E. Cobb, and J. D. Corbin, Regulatory subunit of cAMP-dependent protein kinase inhibits phosphoportein phosphatase. Biochem. Biophys. Res. Comm. 130:567–573 (1985).PubMedCrossRefGoogle Scholar
  8. 8.
    K. Krzystyniak and J. M. Dupuy, Entry of mouse hepatitis virus 3 into cells, J. Gen. Virol. 65:227–231 (1984) .PubMedCrossRefGoogle Scholar
  9. 9.
    H. Maeno and P. Greengard, Phosphoprotein phosphatases from rat cerebral cortex. Subcellular distribution and characterization, J. Biol. Chem. 247:3269–3277 (1972).PubMedGoogle Scholar
  10. 10.
    L. Mallucci, Effect of chloroquine on lysosomes and on growth of mouse hepatitis virus (MHV3) , Virol. 28:355–362 (1986).Google Scholar
  11. 11.
    L. Mizzen, A. Hilton, S. Cheley, and R. Anderson, Attenuation of murine Coronavirus infection by ammonium chloride, Virol. 142:378–388 (1985).CrossRefGoogle Scholar
  12. 12.
    D. V. Mohandas and S. Dales, In-vivo and in-vitro models of demyelinating disease. An endosomal phosphoprotein phosphatase active on the nucleocapsid protein of a murine Coronavirus. Submitted for publication.Google Scholar
  13. 13.
    S. G. Robbins, M. F. Frana, J. J. McGowan, J. F. Boyle, and K. V. Holmes, RNA-binding proteins of Coronavirus MHV: Etection of monomeric and multimeric N protein with an RNA overlay in protein blot assay, Virol. 150:402–410 (1986).CrossRefGoogle Scholar
  14. 14.
    G. A. R. Wilson, S. Beushausen, and S. Dales, In-vivo and in-vitro models of demyelinating disease. XV. Differentiation in primary explants of mouse CNS, Virol. 151:253–264 (1986).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • G. A. R. Wilson
    • 1
  • D. V. Mohandas
    • 1
  • S. Dales
    • 1
  1. 1.Cytobiology Group, Dept. of Microbiology and ImmunologyUniv. of Western OntarioLondonCanada

Personalised recommendations